Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-10

Clinical Trial Update: Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas [Phase 2]

View source ↗

Summary

This Phase 2 trial of Avastin in combination with temozolomide for unresectable or multifocal glioblastoma and gliosarcoma has completed and results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)
  • Temodar (Temozolomide)

Snippet

Sponsor: Duke University | Conditions: Glioblastoma, Gliosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2012-09-10